ArticleACS omega2026
Three-Dimensional Response-Surface Models to Predict the Diameter of Electrospun Polycaprolactone Nanofibers: Application in the release of ferulic acid.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Controlling the diameter of electrospun polymeric nanofibers is essential for optimizing their performance in localized drug delivery applications. In this context, mathematical models able to use processing parameters to predict nanofiber dimensions remain limited. In this work, a series of polycaprolactone nanofibers synthesized across a wide diameter range (727-2925 nm) were initially fabricated by the electrospinning method to be subsequently evaluated for localized drug release applications. The nanofiber diameter was systematically varied by adjusting the flow rate and the solvent composition during nanofiber fabrication, while keeping the polymer mass constant. After that, three-dimensional response-surface models were developed, revealing a logarithmic dependence of the nanofiber diameter on the flow rate and an inverse dependence on the solvent ratio. Importantly, both the polymer mass flux through the Taylor cone and the solution viscosity were found to be derived variables, rather than independent, governed by the flow rate and solvent composition, respectively. To connect nanofiber fabrication with drug delivery performance, ferulic acid was selected as a model bioactive compound, and it was incorporated into the nanofibers at three loading levels (0.5, 2, and 6 wt %). Release studies, monitored by high-performance liquid chromatography and ultraviolet-visible spectroscopy, showed that the release behavior was strongly dependent on the ferulic acid content and on the electrospinning processing conditions, whereas no direct dependence on the nanofiber diameter alone was observed. Finally, a kinetic analysis using Higuchi, Peppas-Sahlin, and first-order models revealed that a purely diffusive mechanism does not apply. Instead, the release follows either a first-order or a Peppas-Sahlin model depending on the flow rate used during fabrication. These findings demonstrate that the processing parameters that govern nanofiber diameter also control the internal drug distribution and, consequently, the release kinetics, providing a unified framework for the rational design of electrospun drug delivery systems.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.